Publication:
Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study

dc.contributor.authorGómez-Acebo, Inés
dc.contributor.authorDierssen-Sotos, Trinidad
dc.contributor.authorde Pedro, María
dc.contributor.authorPerez-Gomez, Beatriz
dc.contributor.authorCastaño-Vinyals, Gemma
dc.contributor.authorFernández-Villa, Tania
dc.contributor.authorPalazuelos-Calderón, Camilo
dc.contributor.authorAmiano, Pilar
dc.contributor.authorEtxeberria, Jaione
dc.contributor.authorBenavente, Yolanda
dc.contributor.authorFernández-Tardón, Guillermo
dc.contributor.authorSalcedo-Bellido, Inmaculada
dc.contributor.authorCapelo, Rocío
dc.contributor.authorPeiró, Rosana
dc.contributor.authorMarcos-Gragera, Rafael
dc.contributor.authorHuerta, José María
dc.contributor.authorTardón, Adonina
dc.contributor.authorBarricarte, Aurelio
dc.contributor.authorAltzibar, Jone M
dc.contributor.authorAlonso-Molero, Jéssica
dc.contributor.authorDávila-Batista, Verónica
dc.contributor.authorAragones, Nuria
dc.contributor.authorPollan-Santamaria, Marina
dc.contributor.authorKogevinas, Manolis
dc.contributor.authorLlorca, Javier
dc.contributor.funderGovernment of Catalonia (España)
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderMinisterio de Economía y Competitividad (España)
dc.contributor.funderRed Temática de Investigación Cooperativa en Cáncer (RTICC) (España)
dc.contributor.funderRegional Government of Andalusia (España)
dc.contributor.funderGeneralitat Valenciana (España)
dc.contributor.funderBasque Government (España)
dc.contributor.funderUnión Europea. Comisión Europea
dc.contributor.funderAsociación Española Contra el Cáncer
dc.date.accessioned2019-05-21T07:54:40Z
dc.date.available2019-05-21T07:54:40Z
dc.date.issued2018-09-21
dc.description.abstractBACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used despite their risk of gastrointestinal bleeding or cardiovascular events. We report the profile of people taking NSAIDs in Spain, and we include demographic factors, health-related behaviours and cardiovascular disease history. METHODS: Four thousand sixtyparticipants were selected using a pseudorandom number list from Family Practice lists in 12 Spanish provinces. They completed a face-to-face computerized interview on their NSAID consumption, demographic characteristics, body mass index, alcohol and tobacco consumption and medical history. In addition, participants completed a self-administered food-frequency and alcohol consumption questionnaire. Factors associated with ever and current NSAID consumption were identified by logistic regression. RESULTS: Women consumed more non-aspirin NSAIDs (38.8% [36.7-41.0]) than men (22.3 [20.5-24.2]), but men consumed more aspirin (11.7% [10.3-13.2]) than women (5.2% [4.3-6.3]). Consumption of non-aspirin NSAIDs decrease with age from 44.2% (39.4-49.1) in younger than 45 to 21.1% (18.3-24.2) in older than 75, but the age-pattern for aspirin usage was the opposite. Aspirin was reported by about 11% patients, as being twice as used in men (11.7%) than in women (5.2%); its consumption increased with age from 1.7% (< 45 years old) to 12.4% (≥75 years old). Aspirin was strongly associated with the presence of cardiovascular risk factors or established cardiovascular disease, reaching odds ratios of 15.2 (7.4-31.2) in women with acute coronary syndrome, 13.3 (6.2-28.3) in women with strokes and 11.1 (7.8-15.9) in men with acute coronary syndrome. Participants with cardiovascular risk factors or diseases consumed as much non-aspirin NSAID as participants without such conditions. CONCLUSIONS: Non-aspirin NSAIDs were more consumed by women and aspirin by men. The age patterns of aspirin and non-aspirin NSAIDs were opposite: the higher the age, the lower the non-aspirin NSAIDs usage and the higher the aspirin consumption. People with cardiovascular risk factors or diseases consumed more aspirin, but they did not decrease their non-aspirin NSAIDs usage.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis work was partially funded by the “Accion Transversal del Cancer”, approved on the Spanish Ministry Council on the 11th October 2007; The Instituto de Salud Carlos III-FEDER [PI08/1770, PI08/0533, PI08/1359, PI09/00773-Cantabria, PI09/01286-León, PI09/01903-Valencia, PI09/02078-Huelva, PI09/01662-Granada, PI11/01403, PI11/01889-FEDER, PI11/00226, PI11/01810, PI11/02213, PI12/00488, PI12/00265, PI12/01270, PI12/00715, PI12/00150, PI14/01219, PI14/0613, PI15/00069, PI15/00914, PI15/01032]; The Fundación Marqués de Valdecilla [API 10/09]; The ICGC International Cancer Genome Consortium CLL (The ICGC CLL-Genome Project is funded by Spanish Ministerio de Economía y Competitividad (MINECO) through the Instituto de Salud Carlos III (ISCIII) and Red Temática de Investigación del Cáncer (RTICC) del ISCIII (RD12/0036/0036)); The Junta de Castilla y León [LE22A10–2]; The Consejería de Salud of the Junta de Andalucía [2009-S0143]; The Conselleria de Sanitat of the Generalitat Valenciana [AP_061/10]; The Recercaixa [2010ACUP 00310]; The Regional Government of the Basque Country; The Consejería de Sanidad de la Región de Murcia; The European Commission [grants FOOD-CT-2006-036224-HIWATE]; The Spanish Association Against Cancer (AECC) Scientific Foundation; The Catalan Government DURSI [grant 2014SGR647]; The Fundación Caja de Ahorros de Asturias; and the University of Oviedo.es_ES
dc.format.number1es_ES
dc.format.page1134es_ES
dc.format.volume18es_ES
dc.identifier.citationBMC Public Health. 2018 Sep 21;18(1):1134.es_ES
dc.identifier.doi10.1186/s12889-018-6019-zes_ES
dc.identifier.e-issn1471-2458es_ES
dc.identifier.issn1471-2458es_ES
dc.identifier.journalBMC public healthes_ES
dc.identifier.pubmedID30241493es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/7616
dc.language.isoenges_ES
dc.publisherBioMed Central (BMC)
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI08/1770es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI08/0533es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI08/1359es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI09/00773es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI09/01286es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI09/01903es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI09/02078es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI09/01662es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI11/01403es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI11/01889-FEDERes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI11/00226es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RD12/0036/0036es_ES
dc.relation.publisherversionhttps://doi.org/10.1186/s12889-018-6019-zes_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectAspirines_ES
dc.subjectCardiovascular riskes_ES
dc.subjectGastrointestinal bleedinges_ES
dc.subjectNon-steroidal anti-inflammatory drugses_ES
dc.subjectPropionateses_ES
dc.subject.meshAdultes_ES
dc.subject.meshAge Distributiones_ES
dc.subject.meshAgedes_ES
dc.subject.meshAnti-Inflammatory Agents, Non-Steroidales_ES
dc.subject.meshAspirines_ES
dc.subject.meshCardiovascular Diseaseses_ES
dc.subject.meshCase-Control Studieses_ES
dc.subject.meshFemalees_ES
dc.subject.meshGastrointestinal Hemorrhagees_ES
dc.subject.meshHumanses_ES
dc.subject.meshMalees_ES
dc.subject.meshMiddle Agedes_ES
dc.subject.meshRisk Factorses_ES
dc.subject.meshSex Distributiones_ES
dc.subject.meshSpaines_ES
dc.titleEpidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain studyes_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication4b7eabf1-df99-4684-9c92-42bc37de6a41
relation.isAuthorOfPublication57cdf9f1-5836-41aa-9880-cf773b0e65f9
relation.isAuthorOfPublicationbdb2687b-1299-4a83-9603-d7d83ab19b62
relation.isAuthorOfPublicationcb3b77d8-c78c-4238-9b9d-c1171ff3ab51
relation.isAuthorOfPublication.latestForDiscovery4b7eabf1-df99-4684-9c92-42bc37de6a41
relation.isFunderOfPublicationc6fbffec-abb4-4f0e-81e0-3b254d5dd85d
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublicationefa64f05-b985-4984-8f1e-5fc4ef21f502
relation.isFunderOfPublication77b2fc20-6311-4e46-98a7-83e46257b93b
relation.isFunderOfPublication3fb2c806-a1bc-429e-99df-4c2e50f8a129
relation.isFunderOfPublicationa16348d3-7483-4017-92f4-0f4f47980d57
relation.isFunderOfPublication842e6617-7822-4501-a927-7e8cedda4aa6
relation.isFunderOfPublication6b0fdff7-65d0-4c97-9d9f-0ddb2b20aabe
relation.isFunderOfPublication639cecfa-9455-4e7f-9f65-9ece17a878f0
relation.isFunderOfPublication453a1189-9bca-4be8-8d60-695f50fe028b
relation.isFunderOfPublication.latestForDiscoveryc6fbffec-abb4-4f0e-81e0-3b254d5dd85d
relation.isPublisherOfPublication4fe896aa-347b-437b-a45b-95f4b60d9fd3
relation.isPublisherOfPublication.latestForDiscovery4fe896aa-347b-437b-a45b-95f4b60d9fd3

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
EpidemiologyOfNonSteroidal_2018.pdf
Size:
934.49 KB
Format:
Adobe Portable Document Format
Description: